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Summary Statement 
The mammalian DCN-type NEDD8 E3 ligases have overlapping and unique functions that 
are mostly governed by their unique N-termini.  
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Abstract  
 
Cullin-RING ligases (CRL) are ubiquitin E3s that bind substrates through variable 
substrate-receptor proteins. CRLs are activated by attachment of the ubiquitin-like 
protein NEDD8 to the Cullin subunit and DCNs are NEDD8 E3 ligases that promote 
neddylation. Mammalian cells express five DCN-like proteins and little is known 
about their specific functions or interaction partners. We found that DCNLs form 
stable stoichiometric complexes with CAND1 and Cullins that can only be neddylated 
in the presence of substrate adaptor. These DCNL-CUL-CAND1 complexes may 
represent “reserve” CRLs that can be rapidly activated when needed. We further found 
that all DCNLs interact with most Cullin subtypes, but that they are likely responsible 
for the neddylation of different subpopulations of any given Cullin. This is consistent 
with the fact that the subcellular localization of DCNLs in tissue culture cells differs 
and that they show unique tissue specific expression patterns in mice. Thus, the 
specificity between DCNL-type NEDD8 E3 enzymes and their Cullin substrates is 
only apparent in well-defined physiological contexts and related to their subcellular 
distribution and restricted expression. 
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Introduction 
Ubiquitin is a small (8kDA) signalling protein that regulates most cellular activities. 
The majority of ubiquitin’s functions require its linkage to other proteins via isopeptide 
bonds. This is mediated by the sequential action of three enzymes, termed E1, E2 and 
E3 (Hershko and Ciechanover, 1998). E3 enzymes are much more numerous (~600 E3s) 
than E1 (2 proteins) and E2 enzymes (~ 40 proteins), reflecting their role as substrate 
specificity factors of the reaction (Hershko and Ciechanover, 1998). By far the largest 
class of E3 enzymes is formed by the Cullin-RING ligase (CRL) family. These are 
modular E3s built around a heterodimeric catalytic scaffolding complex that consists of 
a small RING-finger protein (either RBX1 or RBX2), which is bound to the C-terminus 
of a Cullin protein. The N-terminus of Cullins can interact with many different 
substrate-specificity modules that recruit substrates, while the RING finger protein 
interacts with ubiquitin-charged E2 enzymes (Petroski and Deshaies, 2005). 
Mammalian cells contain eight Cullin proteins, Cul1, Cul2, Cul3, Cul4A, Cul4B, Cul5, 
Cul7 and Cul9/Parc8 (Sarikas et al., 2011) and although only a limited number of CRL 
complexes have assigned substrates, it is estimated that ~300 CRL complexes exist in 
humans (Enchev et al., 2015). 
The assembly and activity of CRLs is regulated through reversible conjugation of 
NEDD8, a ubiquitin-like protein, to a conserved lysine residue in the Cullin backbone 
(Lammer et al., 1998, Liakopoulos et al., 1998) (Pintard et al., 2003) (Lyapina et al., 
2001) (Bornstein et al., 2006) (Cope et al., 2002). NEDD8 modification activates CRLs 
by inducing structural flexibility of the Cullin C-terminus, allowing RBX1 and RBX2 to 
adopt productive conformations for the transfer of ubiquitin onto substrates (Duda et al., 
2008). Neddylation and de-neddylation of Cullins are also important to regulate CRL 
composition, as only de-neddylated complexes can interact with the exchange factor 
CAND1 that regulates the release of old and the association of new substrate adaptors to 
Cullin-RING core complexes (Goldenberg et al., 2004, Liu et al., 2002, Zemla et al., 
2013, Zheng et al., 2002) (Pierce et al., 2013) (Wu et al., 2013). Like ubiquitin, NEDD8 
becomes conjugated to its Cullin substrates by E1, E2 and E3 enzymes (Kurz et al., 
2005) (Rabut and Peter., 2008) (Rabut et al., 2011). The single E1 NEDD8-activating 
enzyme (NAE) is a heterodimer of two proteins, APP-BP1(ULA1) and UBA3 (Walden 
et al., 2003).  Two NEDD8 E2 conjugating enzymes are encoded by UBE2M and 
UBE2F (Huang et al., 2009). In addition to being ubiquitin E3s, RBX1 and RBX2 are 
also NEDD8 E3s that transfer NEDD8 onto the Cullins they are bound to, but they 
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require auxiliary E3 factors to direct NEDD8 towards the right lysine residue (Scott et 
al., 2010).  These factors are encoded by proteins of the DCN1 (defective-in-cullin-
neddylation-1) family. In lower organisms, single DCN1 homologs exist that promote 
the neddylation of all Cullins (Kurz et al., 2005, Kurz et al., 2008), while multiple 
DCN1 molecules are encoded by the genomes of higher organisms. Human cells, for 
example, express 5 DCN1-like proteins termed DCNL1–DCNL5 (also named 
DCUN1D1–5 for defective in Cullin neddylation 1 domain-containing protein 1–5 or 
SCRRO1-5) (Bommelje et al., 2013, Sarkaria et al., 2006) (Meyer-Schaller et al., 2009) 
(Kim et al., 2008) (Huang et al., 2014). These DCNLs have distinct amino-terminal 
domains, but share a conserved C-terminal potentiating neddylation (PONY) domain. 
The PONY domain directly binds to Cullins through invariant residues, called the DAD 
patch (D226, A253, D259 in Saccharomyces cerevisiae Dcn1), while the function of the 
variable N-terminal domains are largely unclear (Kurz et al., 2005). The N-terminus of 
yeast Dcn1 encodes a ubiquitin-binding UBA domain, which is also present in the 
human DCNL1 and DCNL2 isoforms. While conserved, the UBA domain is not 
required for DCN1s neddylation activity in vitro or in vivo and its function remains to 
be determined (Kurz et al., 2008) (Wu et al., 2011).  The regulation of DCNL activity in 
general appears to be important, as DCNL1 is highly amplified in various tumors where 
it acts as an oncogene (squamous cell carcinoma-related oncogene) (Broderick et al., 
2010, Sarkaria et al., 2006) and DCNL5 (DCUN1D5) was also recently reported to be 
overexpressed in some oral and lung squamous cell carcinomas (Bommelje et al., 2013). 
Consistent with these observations, inhibition of neddylation by a small molecule drug 
(MLN4924) shows promise in clinical trials for the treatment of haematological 
malignancies (Soucy et al., 2009).   
While DCNL1 and DCNL2 contain N-terminal UBA domains, DCNL3, DCNL4 and 
DCNL5 contain unique N-termini that are predicted to be unstructured. In general, the 
N-termini are thought to govern the subcellular localization of DCNs or their Cullin 
specificity. However, comprehensive evidence in support of this hypothesis is missing, 
except for DCNL1 and DCNL3 (Wu et al., 2011)(Meyer-Schaller et al., 2009).  
Here we have explored the specificity and interactions of the different mammalian 
DCNL homologues. We find that in cells all DCNLs interact strongly with most Cullins 
and CAND1, a known regulator of CRLs that is required to exchange substrate adaptors 
(Liu et al., 2002, Zheng et al., 2002). We further find that the five mammalian DCNLs 
are widely expressed in tissue culture cells, but differ in their subcellular localization 
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patterns. The expression of DCNLs in animal tissue is more restricted, where DCNL1 
seems to be the only broadly expressed DCNL. In tissue culture cells, none of the 
DCNLs shows specificity towards a Cullin subtype, supporting a model whereby all or 
most DCNLs contribute to the overall neddylation levels of Cullins. However, it also 
suggests that DCNLs are not simply redundant, but instead neddylate distinct 
subpopulations of Cullins. One striking example is the non-redundant contribution of 
DCNL1 and DCNL5 to the neddylation of Cullin4A. Our findings thus suggest that 
while DCNLs appear to indiscriminately neddylate Cullins, they maintain unique 
functions that are not redundant with other DCNLs.  
 
Results: 
DCNLs interact with Cullins and CAND1 
Using HEK-293 cell lines stably expressing N-terminally FLAG-tagged isoforms of 
each DCNL, we determined their interaction partners by mass spectrometry (MS) after 
FLAG-immunoprecipitation (Kurz et al., 2008) (Fig. 1A, B, C). Using SDS-PAGE gels 
followed by silver staining (Fig.1A), we detected unique interaction patterns for each 
DCNL, with the exception of one protein at >100kDa, that was prominently present in 
all immunoprecipitates, but too large to be a Cullin. All the specific interactors were lost 
when the DAD patch was mutated, suggesting that the interactions are mediated by 
Cullins.   
The mass-spectrometry (MS) analyses revealed that most DCNLs interacted with most 
Cullin subtypes (Cul1, -2, -3, -4A, -4B and -5) with the exception of Cul7 and Cul9 
(Fig. 1B). There was no readily apparent difference in the binding to the different 
Cullins, except for DCNL4, which appeared to be overall binding less to Cul3 and did 
not bind to Cul4A or Cul4B (Fig. 1B). However, this apparent lack of interaction was 
likely due to the very low expression level of FLAG-DCNL4 in our cell line compared 
to the other cell lines. This resulted in significantly less FLAG-DCNL4 being 
immunoprecipitated (Fig. 1C), which may have dropped the amount of co-precipitated 
Cul4A and Cul4B below the detection limit. Nevertheless, from these results we 
concluded that no DCNL has a readily apparent Cullin preference in cells. This is in 
accordance with previously published in vitro data that showed that purified 
recombinant DCNLs can bind to all Cullins with only slightly different affinities 
(Monda et al., 2013). Our results now suggest that in cells, DCNLs are indeed capable 
of binding to most if not all Cullins indiscriminately. Interestingly, when we went on to 
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confirm the identified interactions by Western blotting (Fig. 1C) we found that DCNLs 
only interacted with non-neddylated Cullins, strongly suggesting that they are released 
from the Cullin complexes once they are neddylated. Consistent with the low expression 
levels of our FLAG-DCNL4 cell line, we were unable to confirm by Western blot the 
interactions between FLAG-DCNL4 and the binding partners identified by mass 
spectrometry.  
In the mass spectrometry analysis we found very few additional proteins outside of 
Cullins that specifically bound to DCNLs. DCNL1,  2,  3 and 5 also interacted with 
other regulators or subunits of Cullin-RING ligases such as RBX1, RBX2, Elongin B 
(Cul2 substrate adaptor), and DDB1 (Cul4A substrate adaptor). The only non-Cullin 
related interactor we identified was the mitochondrial protein ACADVL that bound to 
DCNL5.  We could, however, not independently confirm this interaction by Western 
Blotting, casting doubt on the validity of this interaction (Fig. S1). 
Most strikingly, we detected a very strong interaction of all DCNLs with CAND1 (Fig. 
1B). This was surprising, as CAND1 only binds to non-neddylated Cullins and prevents 
their neddylation when bound (Liu et al., 2002, Zheng et al., 2002). Based on peptide 
counts CAND1 was the strongest interactor for all DCNs, and by size, it fit the large 
protein that we had readily identified on silver-stained gels (Fig. 1A). A mutation of the 
DAD patch on DCNLs abolished binding to all Cullins, but also to CAND1, suggesting 
that the interaction is bridged by Cullins (Fig. 1C). Indeed, all DCNLs were able to 
form stable stoichiometric heterotrimeric complexes in vitro with recombinantly 
expressed CAND1 and the Cullin Cul3/Rbx1 (Fig 2A-E). Formation of the complexes 
in vitro was dependent on the presence of Cul3/Rbx1, and we could not detect a direct 
interaction between any DCNL and CAND1 (Fig. 2A-E). Thus, DCNLs can form stable 
stoichiometric complexes with Cullins and CAND1 that are bridged by the Cullin 
protein.  
Given that CAND1-Cullin complexes are resistant to neddylation, we next tested if this 
was also true for CAND1-Cul3-DCNL complexes. We could show in vitro that the 
presence of CAND1 strongly inhibited the neddylation of Cul3/Rbx1 irrespective of the 
presence of any DCNL in the complex (Fig. 2F-J). These results posed the question why 
such complexes of Cul/CAND/DCNL would form in the first place. One possibility was 
that they represent reservoir Cullin complexes that are inactive, but primed for 
neddylation and thus rapid activation when needed. As active complexes need to bind to 
substrates, we reasoned that the inactive complexes may become activated in the 
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presence of substrate adaptor. Indeed, the addition of stoichiometric amounts of the 
Cul3 substrate adaptor KLHL3 to the in vitro reaction overcame the CAND1 dependent 
inhibition of neddylation (Fig. 2F-J). It is thus highly plausible that heterotrimeric 
CAND1-Cullin-DCN complexes exist in the cell to allow rapid activation by 
neddylation as soon as they encounter substrate adaptor complexes.  
 
DCNLs differ in their subcellular localization and expression profiles. 
Based on our mass spectrometry results, all DCNLs are able to interact with most 
Cullins. We thus next tried to understand if they are fully redundant or also have unique 
functions. We first determined their expression profiles in mouse tissue and tissue 
culture cells. Using specific antibodies for each family member (Fig. S2), we found that 
all DCNLs are well expressed in the three tissue culture cell lines we tested (HEK-293, 
U2OS and HeLa) (Fig. 3A). DCNL1 and DCNL2 are expressed to similar levels in all 
three cell lines. DCNL3 expression is comparatively low, but it is best expressed in 
U2OS cells and less abundantly in HeLa and HEK-293 cells (Fig. 3A). DCNL4 is 
predicted to have at least three splice variants (29kDa, 34kDa, 38kDA), and we can 
detect at least two of these isoforms in tissue culture cells to relatively high levels, but 
most strongly in HEK-293 cells (Fig. 3A).  Strikingly, DCNL5 is the most strongly 
expressed DCNL in all cell lines tested, suggesting that it may have a major role in 
proliferating cells (Fig. 3A). 
This general expression is in stark contrast to DCNL expression in mouse tissue. Here, 
DCNL5 was the least expressed of all DCNLs (Fig. 3A). DCNL1, on the other hand, 
was the most widely expressed isoform and could easily be detected in all tissues (Fig. 
3A). DCNL2, although very similar in sequence to DCNL1, was not expressed as 
widely and mostly found in liver and kidney and, as what appeared to be a highly post-
translationally modified form, in brain (Fig. 3A). Expression of DCNL3 was mostly 
restricted to testis and brain. The expression of different DCNL4 isoforms, was more 
widely detectable, but most strongly in testis, brain, heart, liver, and kidney (Fig. 3A).  
DCNL4 was predominantly expressed as the 34 kDa isoform, except in testis, where the 
smaller 29 kDa isoform was predominant, and in brain, where the 38 kDa and the 
29kDa isoforms were expressed to approximately equal levels (Fig. 3A). DCNL5 was 
only detectable at low levels in testis, skin, and immune tissues (thymus, spleen and 
lymph nodes) with the highest expression in thymus and testis, suggesting that DCNL5 
has unique functions in these cells (Fig. 3A and Fig. S3).  
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DCNL1 is the evolutionarily oldest DCN isoform and most closely related to the single 
homologs found in lower organisms, and it may therefore also function as the main 
DCNL for Cullin complexes in mammalian cells (Kurz et al., 2005). However, DCNL1 
cannot be solely responsible for the neddylation of all Cullins, as DCNL1 knock-out 
mice are viable, which would not be expected if all Cullins were affected by the 
deletion of DCNL1 (Huang et al., 2011). Thus, the other DCNLs likely regulate the 
activity of certain subpopulations of CRL complexes. The restricted expression pattern 
of most DCNLs suggests that these functions could be tissue-specific. However, as no 
knock-out animals for any of the other DCNLs exist, we decided to investigate the 
potential specificities in tissue culture cells, bearing in mind that some of the specific 
effects may be masked due to the strong expression of most DCNLs in this 
experimental system.  
Previous work using recombinant proteins and in vitro assays, demonstrated that all 
recombinant DCNLs bind all Cullins with only slightly different affinities and can 
promote their neddylation in vitro (Monda et al., 2013). Our immunoprecipitation 
analysis is less sensitive, and it is difficult to comment on the relative affinities in cells 
using our methodology. However, we do find that most DCNLs bind to all Cullins in 
our analysis with the exception of DCNL4 that does not interact with Cul4A or Cul4B. 
Furthermore, all human DCNLs can rescue the neddylation defect of yeast DCN1 
knock-out cells when overexpressed (Meyer-Schaller et al., 2009) demonstrating that 
they are all capable of neddylating Cullins, which we could confirm with our in vitro 
reconstitution of neddylation. We thus concluded that it is likely that distinct subcellular 
localization or binding partners, rather than different affinities for different Cullin 
subtypes, would mediate any specificity in the system.  
To investigate potential differences in subcellular localization, we utilized stably 
expressing FLAG-DCNL U2OS cell lines to determine their localization by indirect 
immunofluorescence with a FLAG antibody. This revealed that while there is some 
overlap in their localization, DCNLs do have unique localization patterns (Fig. 3B). We 
found that DCNL1 and DCNL2 localize to both the nucleus and the cytoplasm of cells 
as previously described (Huang et al., 2011) (Fig. 3B). DCNL3 was present at the 
plasma membrane, in the cytoplasm and nucleus (Ma et al., 2008, Meyer-Schaller et al., 
2009)  (Fig. 3B), while both, DCNL4 and DCNL5 were almost exclusively nuclear (Fig. 
3B).  As both DCNL1 and DCNL3 subcellular localization is governed by their 
respective N-termini, we reasoned that this might also be the case for DCNL4 and 
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DCNL5 (Wu et al., 2011). Indeed, both their N-termini harbor a putative nuclear 
localization signal (NLS) (Bommelje et al., 2013) and its mutation in DCNL5 led to a 
diffusion of the protein into the cytoplasm (Fig. 3C,D). This mutant form of DCNL5 is, 
however, not entirely excluded from the nucleus, as it is small enough to passively 
diffuse through the nuclear pore (27.5 kDa) (Fig. 3D). Interestingly, mutation of the 
DAD patch motif, which disrupts Cullin binding, does not change the localization of 
any DCNL, which demonstrates that the subcellular localization of DCNLs is 
independent of the interaction with Cullins, and must be mediated by other 
determinants, likely their unique N-termini (Fig. 3C).   
 
DCNLs do not display a strong Cullin preference in cells 
The interaction data suggests that in tissue culture cells all DCNLs likely contribute to 
the neddylation of all Cullins. To examine if this was the case and to determine the 
relative contribution of each DCNL to the overall steady-state neddylation level of 
Cul1, -2, -3, -4A, 4B, and -5, we downregulated the expression of each DCNL by 
siRNA and determined the changes in Cullin neddylation by Western Blot (Fig. 4A). As 
expected from our interaction data, downregulation of single DCNLs did not drastically 
affect the overall Cullin neddylation levels, indicating that there is strong functional 
overlap between the different DCNL homologs in tissue culture cells (Fig. 4A). 
However, downregulation of some DCNLs affected some Cullins more strongly than 
others. For example, while down-regulation of DCNL1 appeared to slightly affect the 
neddylation of all Cullins, it had a most prominent effect on Cul1 and Cul4A (Fig. 4A). 
This is quite similar to the down-regulation of DCNL5, which also affected Cul1 and 
Cul4A (Fig. 4A). DCNL4 downregulation, on the other hand, only slightly affected the 
neddylation of Cul5 and Cul4B (Fig. 4A). Curiously, downregulation of DCNL3 
increased neddylation of Cul1, Cul3, Cul4A and Cul4B (Fig. 4A), which suggests that 
DCNL3 may in some instances inhibit Cullin neddylation instead of promoting it 
(Huang et al., 2014). Thus, at least in tissue culture cells, there is not a single DCNL 
that is predominantly required for the neddylation of any one Cullin. Instead, the 
different DCNLs appear to contribute to the overall neddylation pattern of most Cullins.  
However, given that siRNA downregulation may not remove all protein from the cell, it 
was possible that any remaining protein was sufficient to neddylate Cullins and to thus 
mask more specific requirements. In order to explore this possibility, we generated 
knock-out (KO) cell lines for DCNL1 and DCNL5 using the CRISPR/Cas9 method in 
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U2OS cells (Ran et al., 2013) (Munoz et al., 2014) (Mali et al., 2013) (Heigwer et al., 
2014) (Fig. 4B). Similar to siRNA-mediated downregulation, a complete knock-out of 
DCNL1 or DCNL5 did not entirely abolish the neddylation of any one Cullin (Fig. 4C).  
However, it did more significantly affect the neddylation of most Cullins compared to 
siRNA mediated knock-down of DCNL1 and DCNL5 (Fig 4A,C). Knock-out of 
DCNL1 reduced the neddylation of Cul1, Cul3, Cul4A and Cul5, but left Cul2 and 
Cul4B unaffected (Fig. 4C).   DCNL5 knock-out, on the other hand, affected all Cullins 
tested (Fig. 4E). However, neither knock-out affected the neddylation of any Cullin to 
more than approximately 25% of the parental cell line (Fig 4C). The effects we see on 
the neddylation of different Cullins does not directly correlate with the reported 
affinities in (Monda et al., 2013) or our slight differences in interaction between Cullins 
and DCNLs as analysed by mass spectrometry. However, given that the different 
affinities are ultimately very similar, it is not surprising that other factors govern which 
Cullin is predominantly affected by a specific DCNL. Overall these results again 
highlight the fact that different DCNLs contribute to the steady-state neddylation level 
of many Cullins, but they also suggest that distinct DCNLs are responsible for the 
neddylation of a given subpopulation of a Cullin, as if they were entirely redundant, we 
would not expect to detect any effects on Cullin neddylation upon loss of a single 
DCNL. Thus, DCNLs may have non-redundant functions with respect to certain Cullin 
subpopulations and these could be mediated by differences in their subcellular 
localisation.  
 
DCNL1 and DCNL5 independently contribute to Cullin4A neddylation, but only 
DCNL5 affects the DNA damage response 
To test whether this was the case, we more closely examined the effect of DCNL1 and 
DCNL5 knock-out on Cul4A, as both knock-out cell lines showed a reduction of Cul4A 
neddylation (Fig. 4C). This reduction, albeit mild, could be rescued by re-expressing 
wild type DCNL1 or DCNL5 but not DAD patch mutant forms (Fig. 5A-D).  Additional 
siRNA mediated knock-down of DCNL5 in the DCNL1 knock-out cell line or DCNL1 
in the DCNL5 knock-out cell line, further reduced Cul4A neddylation levels, which 
suggested that DCNL5 and DCNL1 act independently from each other to neddylate 
distinct Cul4A pools (Fig. 5E,F). However, it is unclear which Cul4A pools are affected 
by DCNL1 or DCNL5 and whether they have distinct functions. Cul4A has been 
implicated in processes both in the cytoplasm (Kuang et al., 2013) and in the nucleus 
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(Chen et al., 2001, Nag et al., 2001, Shiyanov et al., 1999) where Cul4A is involved in 
DNA replication and DNA repair (Zhong et al., 2003) (Higa et al., 2003, Hu et al., 
2004). CRL4 complexes are particularly important for the management of UV-induced 
DNA lesions and cells that lack the CRL4 substrate receptor DDB2 are very sensitive to 
UV light (Chu and Chang, 1988) (Scrima et al., 2008) (van Cuijk et al., 2015). 
Given that DCNL1 and DCNL5 affect Cul4A neddylation we asked if they are essential 
for CRL4 dependent DNA damage repair. To test this, we determined sensitivity of the 
knockout cell lines in clonogenic survival assays following UV exposure. We found that 
only DCNL5 knock-out cells showed sensitivity to UV light (Fig. 6A) that could be 
rescued by re-expressing GFP-tagged DCNL5 (Fig. 6A). Thus, DCNL5 knock-out 
sensitizes cells to UV damage, which represents a function that is not shared with 
DCNL1.  
To determine if DCNL5 is involved directly in the DNA damage response, we asked 
whether DCNL5, like Cul4A, localises to sites of DNA damage. We sensitized cells 
with 5-bromo-2’-deoxyuridine (Brdu) or mono-psoralen and subsequently micro-
irradiated the nucleus with a 355-nm UV-A laser to induce DNA lesions along a defined 
track (Lachaud et al., 2014, Perez-Oliva et al., 2015). As previously reported, Cul4A 
localises to this type of DNA damage (Fig. 6B) (Meir et al., 2015) and importantly 
endogenous DCNL5 does as well (Fig. 6B). An exogenously expressed GFP-DCNL5 
version was also recruited to the track of DNA damage and this was independent of the 
interaction with Cullins, as the GFP-DCNL5 DAD patch mutant was similarly recruited 
(Fig. 6C). In DCNL5-DAD patch mutant cells, Cul4A was also still recruited to sites of 
damage, demonstrating that the ability of DCNL5 to bind to Cullins is not required for 
the localisation of Cul4A (Fig. S4A). Thus, we concluded that the sensitivity of DCNL5 
knockout cells to UV induced damage is most likely a direct consequence of its role in 
neddylating Cul4A at sites of damage.  
Because of the lack of UV sensitivity of DCNL1 knockout cells, we expected that 
DCNL5 would be the only DCNL recruited to damage sites. To confirm this 
assumption, we also tested whether any of the other DCNLs localised to sites of 
damage. Contrary to our expectations, we found that all DCNLs were strongly recruited 
(Fig. 6D), with the exception of DCNL3 that was barely detectable at damage sites. It 
thus appears as if most DCNLs may have a role at sites of DNA damage. The 
significance of this finding, however, is unclear at the moment. There may be 
redundancy in the system, but given that the DCNL5 knockout cells show sensitivity to 
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UV-induced DNA damage, while the DCNL1 knockouts do not, it is likely that at least 
the role of DCNL5 at damage sites is to some degree non-redundant.  
DCNL3 is the only DCNL that does not appear to readily go to sites of damage. 
However, even DCNL3 may regulate the DNA damage response, as siRNA to DCNL3 
leads to increased Cul4A neddylation. Whether this effect is direct, by for example 
DCNL3-dependent sequestration of Cul4A in the cytoplasm, or indirect is unclear. 
However, as overexpression of DCNL3 does not lead to a defect in the recruitment of 
Cul4A to sites of DNA damage or to decreased neddylation of Cul4A (Fig. 6E; S4B), it 
is unlikely that the effect is simply mediated via sequestration. Furthermore, when 
we replaced the N-terminus of DCNL3 with that of DCNL5, DCNL3 is now equally 
well recruited to sites of damage than other DCNLs, thus any unique function of 
DCNL3 is mediated by its N-terminus (Fig. 6E), which based on our results is likely 
true for the other DCNLs as well. 
  
 
Discussion 
Cullin Ring Ligases are the largest class of Ubiquitin E3s and because of their 
modularity are able to form complexes that target hundreds of substrates for 
ubiquitylation. This class of E3 ligases share a common regulatory mechanism 
involving neddylation of the central Cullin subunit, which is mediated in part by the 
DCNLs. It has long been puzzling why higher organisms contain multiple DCNLs that 
differ in their N-terminal domains. The most obvious explanation would be that they 
target different Cullin subtypes, allowing the cell to regulate Cullins independently. 
However, this is not the case, as DCNLs show no obvious Cullin preference in cells or 
in vitro, even though small differences in affinities exist. The effects we see on the 
neddylation of different Cullins after DCNL downregulation does, however, not directly 
correlate with the reported differences in affinities (Monda et al., 2013) or our observed 
slight differences in interaction between Cullins and DCNLs as analysed by MS. Other 
factors thus likely govern which Cullin is affected by a specific DCNL. For example, 
given that we found that most DCNLs are in complex with inactive Cullin/RING cores 
and CAND1, it is hard to predict which DCNL interacts with the more “active” 
subpopulation of any given Cullin. For example, while DCNL1 may immunoprecipitate 
overall more Cul5 than DCNL5, it is possible that most DCNL1-bound Cul5 is inactive 
and also bound to CAND1, while the DCNL5-bound Cul5 is more readily engaged with 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
dv
an
ce
 a
rt
ic
le
active complexes. If so, then inactivation of DCNL5 would affect neddylation of Cul5 
more than inactivation of DCNL1, even though more DCNL1 co-precipitates with Cul5. 
So what are the functions of the different DCNLs and how are they regulated? 
Importantly, we now show that in cultured cells the DCNL isoforms show different 
subcellular localization patterns. It is thus feasible that through regulation of different 
DCNL subtypes, the cell specifically regulates Cullin-RING ligase activity in different 
places in the cell. Our data further suggests that compartmentalization is mediated by 
the N-termini, which likely have regulatory functions independent of the actual NEDD8 
E3 activity of DCNLs. Furthermore, studies on DCNL3 have shown that its N-terminus 
is important for localization to the plasma membrane, where it neddylates Cul3 (Meyer-
Schaller et al., 2009). We also find DCNL3 at the plasma membrane, but curiously, 
downregulation of DCNL3 by siRNA increases the neddylation of many Cullins. Thus, 
at least in some instances, DCNL3 appears to inhibit Cullin neddylation (Huang et al., 
2014). The mechanism by which this occurs, however, remains elusive, but we can 
speculate that DCNL3 sequesters Cullins away from the neddylation machinery.  
One surprising result was that all DCNLs strongly interact with CAND1, which was 
counterintuitive, as CAND1 only binds non-neddylated Cullins (Liu et al., 2002, Zheng 
et al., 2002). However, our data unequivocally demonstrates that DCNLs and 
Cullin/RBX1 form hetero-trimeric complexes with CAND1. CAND1 binding prevents 
cullin neddylation by DCNLs, which is counteracted by substrate adaptors. The 
presence of a NEDD8 E3 in a non-neddylatable CRL may be important to allow a rapid 
activation when the need arises. These complexes thus likely represent inactive Cullin 
reservoirs primed for activation by neddylation. Given that we find that DCNLs only 
interact with non-neddylated Cullins, it is likely that DCNLs dissociate upon 
neddylation and that in the cell most DCNLs are in fact present in inactive CRL 
complexes.  
Our data also strongly suggests that all DCNLs contribute to the neddylation of most if 
not all Cullins and it is thus likely that any Cullin can be targeted by any DCNL as long 
as it is present in the same compartment. The system is further complicated by the fact 
that the DCNLs show some overlap in localization. For example, DCNL1 and DCNL2 
are both present in the nucleus and cytoplasm, DCNL3 localizes to the plasma 
membrane, while DCNL4 and DCNL5 are exclusively nuclear. So theoretically, all 
DCNLs, should be able to neddylate nuclear Cullins. However, there are still functional 
differences, as our data suggest that DCNL5 serves a unique role in the DNA damage 
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response even though other DCNLs also localise to sites of DNA damage. Future 
experiments will be required to determine their role, but given the lack of sensitivity of 
DCNL1 knockout cells to UV light, it is possible that DCNL1 acts redundantly with one 
or all of the other DCNLs at damage sites, while DCNL5 retained a unique function. 
Similar to our findings, it was recently shown that the NEDD8 E2s UBE2M and UBE2F 
both go to laser stripes, but only UBE2M depletion made cells sensitive to DNA 
damage (Brown et al., 2015).  
In general, all our data is consistent with a model, whereby depending on the 
localization of a Cullin, it becomes activated by a different DCNL. As a consequence, 
the overall neddylation of the cellular pool of a Cullin would not be strongly affected by 
depletion of single DCNLs, which is what we observed. Furthermore, depletion of two 
DCNLs has additive effects on Cullin neddylation, which further supports the idea that 
different DCNLs are neddylating different subpopulations of the same Cullin. This 
“specialization” may allow the cell to regulate the activity of distinct Cullin pools 
without affecting all CRLs build around one Cullin subtype.  
Furthermore, all DCNLs are widely expressed in tissue culture cells, which is very 
different from what we see on an organismal level where tissue-specific expression is 
apparent. This ectopic expression of most DCNLs may thus to some degree contribute 
to the redundancy of the system in tissue culture. Furthermore, given that at least 
DCNL1 and DCNL5 are oncogenic, it is critically important for the cell to regulate the 
activity of DCNL E3s. Although speculative, it is possible that strong DCNL1 and/or 
DCNL5 expression interferes with regulatory mechanisms on other DCNLs, overriding 
their regulation and facilitating the development of cancer.  
Given these results, it will become important in the future to study these enzymes in 
defined primary cells and relevant physiological contexts to understand their specific 
functions. This will especially be important for the DCNLs that show tissue specific 
expression. These NEDD8 E3s will likely have very unique functions in these tissues 
that are impossible to study in cancer cell lines. To fully understand the specificity, 
regulation and function of all DCNLs will thus require a closer look at tissue-specific 
roles and the generation of animal models that carry deletions or mutations of single 
DCNLs. 
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Material and methods 
Antibodies 
Immunoblotting: anti-FLAG M2 (F3165) (1/2000), anti-DCNL1 Sigma-Aldrich(Clone 
3D7) (1/1000), anti-GAPDH(1/2000), anti-Actin(MAB1501) Millipore (1/1000), anti-
Cullin1(718700) (1/1000) and anti-Cullin2(700179) (1/5000) Life Technologies, anti-
ACADVL (PA5-29959) ThermoScientific, mouse anti-GFP (ab184519) Abcam 
(1/2000). Sheep polyclonals were raised against full-length KLHL3, the N-terminus of 
DCNL3,-4,-5, Cul4A,-B and against the C-terminus of Cul3 and Cul5 and used at 
1g/ml. 
Immunofluorescence: mouse anti-FLAG M2 (F3165)(1/1000) Sigma, chicken anti-GFP 
Abcam(ab13970) (1/1000), sheep anti-DCNL5(1/200), sheep anti-Cullin4A(1/100), 
anti--H2Ax(05-636) (1/1000) from Millipore , secondary antibodies conjugated to 
Alexa Fluor 488 or 594 from Life Technologies (1/1000). 
 
Cell Culture 
U2OS, HEK-293 were grown in GIBCO DMEM with 10% GIBCO FBS,  L-glutamine, 
100 units/mL penicillin, 100 g/ml streptomycin (Life Technologies). 
HEK-293 and U2OS cells stably expressing tagged DCNLs were generated using the 
Flp-In T-Rex system (Life Technologies). Expression was induced with 1 g/mL 
tetracycline (Sigma-Aldrich) overnight. All cell lines used were originally obtained 
from ATCC and regularly tested for contamination. 
 
Cell extracts, immunoprecipitation and immunoblot analyses. 
Whole-cell extracts were prepared by lysis in 50mM Tris-HCl pH7.4, 150mM NaCl, 
1mM EDTA, 1mM EGTA, 50mM sodium fluoride, 5mM sodium pyrophosphate, 
10mM sodium -glycerol-1-phosphate, 1mM sodium orthovanadate, 0.27M sucrose, 
1% Triton X-100, 15mM iodoacetamide, 3mM 1,10 phenanthroline (Sigma-Aldrich) 
and complete phosphatase inhibitor PhosSTOP (Roche). FLAG-tagged proteins were 
isolated by immunoprecipitation from 2-3 mg of lysate using 10 L FLAG(M2)-
magnetic beads (Sigma; 2 hours; 4°C).  
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Immunoprecipitations were washed in lysis-buffer before elution by LDS sample buffer. 
To detect protein in cell lysates, samples were separated by SDS-PAGE, transferred 
onto nitrocellulose or PVDF and visualized by immunoblotting/ECL (Millipore). 
 
RNA interference. 
Transfection was carried out using LipofectamineTM as described previously (Hjerpe et 
al., 2011) ((Hjerpe et al., 2012). SMARTpool siRNA oligos from GE Dharmacon (Little 
Chalfont, UK) were used, siRNA against the DCNL1 3’UTR(5'-
UACAUAGUCUGUACAAUAA-3') was synthesized by Eurofins (Ebersberg, 
Germany). 
 
Cas9/CRISPR knock out cell lines  
The guideRNA vectors for exon 1 in DCNL1 and DCNL5 were generated by 
mutagenesis PCR of pEsgRNA (Munoz et al., 2014). The target sequence for DCNL1 
and DCNL5 were respectively CCAACATGGTGAGGCACTGCGGC and 
GCAGCAGTAGCGGAAGACGGAGG (+ strand 5’-3’). The constructs were 
transfected using genejuice(Millipore) into U2OS stably expressing FLAG-Cas9 under 
tetracycline inducible promoter and single-cell cloned.  
 
Immunofluorescence 
Cells were fixed (10 minutes, 4% paraformaldehyde), permeabilized (5 min; 0.5% 
NP40 in PBS; room temperature); blocked overnight (4°C; 3% IgG-free BSA (Jackson 
ImmunoResearch)  and 0.02% tween in PBS). Cells were stained with anti-FLAG 
(1:2000) followed by anti-mouse Alexa Fluor488 (1:1000), Rhodamine-conjugated 
phalloidin (LifeTechnologies), DAPI (Sigma-Aldrich; 1 g/ml) and mounted using 
Mowiol 4-88 (Polysciences Inc.; Warrington, PA, USA). 
 
Protein expression and purification 
The following purified proteins were previously described in (Kelsall et al., 2013): 
Nedd8 and the APPBP1/UBA3 heterodimer, (Ohta et al., 2013): DAC-TEV-Cul3-
RBX1 and KLHL3, (Schumacher et al., 2015): GST-CAND1. DCNL1,-2,-3,-4 and -5 
were expressed with His6-tags in BL21 and purified by Ni
2+-Sepharose (GE 
Healthcare). GST-DCNL1 and GST-DCNL2 were purified by GSH-Sepharose (GE 
Healthcare). 
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In vitro binding assays 
3.6g his6DCNL were bound to magnetic Ni-NTA beads (Sigma) (4°C; 50 mM Tris-
HCl pH 8.0, and 20% Glycerol). Cul3/CAND1 complexes were formed by incubating 
9.2g Cul3 with 12.4g CAND1 at 4°C. his6DCNL beads were incubated with 
Cul3/CAND1 for 20 min at 4°C, washed 3 times with binding buffer containing 10mM 
Imidazole(Sigma).  Complexes were eluted with 300mM Imidazole and analysed by 
SDS-PAGE and Coomassie staining. 
 
Neddylation assays 
1M Cul3/Rbx1 and 1M DCNL were incubated with 34M NEDD8, 4M UBE2M, 
and 0.2M NAE in reaction buffer (50mM Tris-HCl pH8.0, 0.15mM ATP, 1.5mM 
MgCl2, 20% Glycerol) for 2 min at 30°C, then quenched with LDS buffer. 1M 
CAND1 or 1M CAND1 and 10M KLHL3 were included in some reactions.    
 
Laser irradiation and confocal microscopy. 
U2OS cells were seeded in 35-mm glass bottom dishes at 1x106 cells per dish and 
incubated with mono-psoralen at 25M for 2h or with BrdU at 10M for 24h. A PALM 
MicroBeam system (Carl Zeiss AG, Oberkochen, Germany) was used to irradiate with 
the 355 nm UV laser at 20-25 % for mono-psoralen and BrdUs. Indirect 
immunofluorescence was performed as described previously (Lachaud et al., 2014). A 
minimum of 100 cells were irradiated per replicate. 
 
Induction of DNA damage and colonogenic cell survival assays. 
500 cells were plated in six replicates onto 6 well plates. 24 hours after plating, media 
from cells was aspirated, cells were exposed to UV using a spectrolinker XL-1500 UV 
cross-linker (Spectroline, Westbury, NY). Fresh media was added and colonies were 
grown for 14 days.  Media was aspirated and plates stained with crystal violet(Sigma).  
Colonies with > 100 cells were counted. For each condition, cell viability of untreated 
cells was defined at 100 %. 
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Mass spectrometry analysis. 
After immunoprecipitation and washings with lysis buffer and detergent free buffer 
(100mM Tris HCl pH 8.5),  FLAG-tagged proteins were eluted with acetonitrile/formic 
acid 1% (ratio 1:1). The eluate was dried (speedvac) and resupended in 300l buffer 
containing 1M Urea, 100mM ammonium bicarbonate pH8.0, 5mM DTT (Sigma-
Aldrich), and 0.01% RapiGest(Waters, Milford, MA).  5% of eluate was processed by 
SDS-PAGE on 4-12% gradient gels and silver stained. The remainder was alkylated in 
the dark (60 minutes at 30°C 15mM chloroacetamide (Sigma-Aldrich)).   Samples were 
digested overnight (37°C; 3.75g/mL of MS-grade Trypsin (Promega; Madison,WI).  
Samples were acidified to pH3 (trifluoroacetic acid; Sigma-Aldrich) and centrifuged at 
17,000xg for 5 minutes to remove RapiGest.  Supernatant was bound to c18 columns 
(Harvard Apparatus; Holliston, MA) washed with 0.1% TFA and eluted with 60% 
acetonitrile and 0.1% TFA.  Samples were run on a ThermoScientific Orbitrap Classic.  
RAW Files were analysed with MaxQuant and interaction heatmaps were generate in 
R(R-project). 
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Figures 
 
 
 
Figure 1   
Characterization of DCNL interactors 
A. Silverstained gels of FLAG-immunoprecipitations from HEK293 cells stably 
expressing WT or cullin-binding deficient DAD patch mutants of all mammalian 
DCNLs (DCNL1-5). Asterisks denote FLAG-DCNL proteins. WT but not DAD 
mutants specifically co-immunoprecipitate proteins that are not present in the empty 
FLAG or control, including a large protein with molecular mass > 98kDa (arrow). 
B. Heatmap of DCNL interactors identified by mass spectrometry of 
immunoprecipitations in (A). Interactors with >3 unique peptides detected are plotted.  
All DCNLs co-immunoprecipitate most Cullins, as well as Cullin-associated proteins 
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RBX1, RBX2(RNF7), the Cul4A adaptor protein DDB1 and the Cul2/5 adaptor 
elongin B (TCEB1). Strongest interactor of all DCNLs is CAND1, the CRL substrate 
adaptor exchange factor.  
C. Immunoprecipitation of FLAG-DCNL1-4 (top panels) and FLAG-DCNL5 (bottom 
panels) from stably expressing HEK293 cells followed by western blot analysis. The 
slower migrating of the two Cullin-reactive bands is the neddylated form (asterisk). 
Only WT DCNLs co-immunoprecipitate mostly non-neddylated Cullins, CAND1 and 
RBX1. Expression levels of FLAG-DCNL4 were too low in this experiment to detect 
co-immunoprecipitating proteins. 
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Figure 2 
DCNLs forms a stable complex with Cullin and CAND1. 
A - E. His6DCNL1,-2,-3,-4 and -5 were bound to magnetic Ni-NTA beads, incubated 
for 20 min at 4°C with CAND1 or Cul3/CAND1 complexes and washed with 10 mM 
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Imidazole to reduce nonspecific binding.  Bound proteins were eluted with 300 mM 
Imidazole and separated by SDS-PAGE followed by Coomassie staining. CAND1, 
Cul3 and DCNLs form a stoichiometric complex (lane 7) and CAND1 does not bind 
to any His6DCNL in the absence of Cul3 (lane 6).  
 
F to J. In vitro neddylation reactions of Cul3 show inhibition by CAND1 and rescue with 
substrate adaptor KLHL3. Each reaction contained 1M Cul3 and 1M DCNL and as 
indicated 1M CAND1, 1M KLHL3, or 10M KLHL3.  Neddylation was induced 
by addition to a final concentration of 34M NEDD8, 4 M UBE2M, and 0.2uM 
NAE in 50mM Tris-HCL pH8 with 0.15mM ATP, 1.5mM MgCl2 and 20% Glycerol. 
Reactions were performed for 2 min at 30°C and quenched by the addition of SDS 
loading buffer. Samples were resolved by SDS-PAGE and processed for 
immunoblotting with the indicated antibodies.  Cul3 is readily neddylated in the 
absence of CAND1 as seen from the approximately 10kDa band shift in lane 2 
(asterisk).  Addition of CAND1 inhibits the neddylation reactions, and inhibition is 
relieved upon the addition of Cul3 substrate adaptor KLHL3.  
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Figure 3 
Tissue specific expression and subcellular localization of DCNLs. 
A. DCNLs have unique tissue expression profiles and upregulation in cancer cell lines. 
Western blot analysis of mouse tissue lysates and cancer cell lysates (30mg each) and 
where indicated recombinant protein (50ng). DCNL1 is widely expressed in all tissue 
samples as well as cancer cell lines. DCNL2 expression is more restricted with highest 
expression in the brain, liver and kidneys.  At least one of the 3 isoforms of DCNL4 
are expressed in most tissue, albeit at varying levels.  DCNL3 expression is restricted 
to testis and brain with weak expression in cancer cell lines.  DCNL5 has low 
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expression in testis, skin, thymus, and spleen but is drastically upregulated in the three 
cancer lines.  
B. DCNLs subcellular localization are independent of Cullin binding. U2OS cells 
expressing N-terminally FLAG tagged DCNL1-5 were analyzed by indirect 
immunofluorescence with a FLAG antibody, rhodamine conjugated Phalloidin (actin) 
and DAPI staining. (Scale bars= 10 µm).  DCNL1 and DCNL2 are localized 
throughout the cell in both the cytoplasm and nucleus.  DCNL3 is located throughout 
the cell, but also at the plasma membrane.  DCNL4 and DCNL5 are restricted to the 
nucleus.  Mutation of any of the DCNLs DAD patch domain does not cause a change 
in subcellular localization suggesting DCNLs localization is independent of Cullin 
binding and instead determined by their unique N-terminal domain.  
C. Diagram of each DCNL family member depicting their conserved C-terminal PONY 
domain and specific N-terminal domain.  Depicted on DCNL3 is a myritoylation site 
and depicted on DCNL5 is a nuclear localization sequence (NLS). 
D. Immunofluorescence analysis of U2OS cells stably expressing either GFP-DCNL5 
WT or GFP-DCNL5 with mutations in the NLS (scale bar = 10 µm).  Mutation of the 
NLS sequence results in a relocalisation of DCNL5 into the cytoplasm 
  
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
dv
an
ce
 a
rt
ic
le
 
Figure 4 
 Effects of DCNL downregulation on Cullin neddylation 
A. Knock-down of DCNLs by siRNA has only mild effects on the overall level of 
individual Cullin neddylation.  U2OS cells treated with specific DCNL siRNAs or 
control siRNA for 72 hours, and where indicated the neddylation inhibitor MLN4924 
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was added for 3 hours at 3 mM.  Following treatment, cells where harvested and 
processed for western blotting for the Cullin family members to assess the fraction of 
Cullin that was modified by NEDD8. Knockdown of DCNL1 reduces the amount of 
neddylated Cul1, 4A, and 5, whereas knockdown of DCNL2 or DCNL4 had no effect 
on neddylation levels.  Knockdown of DCNL3 increased Cul1 and Cul4A neddylation 
and DCNL5 knockdown reduced Cul4A and Cul5 neddylation levels.  Adjacent 
graphs show the means (± s.e.m.) of quantified percentage of neddylated Cullins.  
Statistical significance was determined by one-way ANOVA with Newman-Keuls 
Multiple Comparison Test. *P≤0.05 n≥3.  
B. Schematic of DCNL1 and DCNL5 sequences targeted by CRISPR/Cas9 mediated 
gene knockout with Protospacer adjacent motif (PAM) indicated (purple) and Cas9 
cleavage site marked with an arrow.  Depicted below each WT sequence are the 
mutations (in red) as determined by DNA sequencing.  
C. Reduced Cullin neddylation in U2OS knock-out cells (individual clones) for DCNL1 
and DCNL5 generated by CRISPR/Cas9.  Whole cell lysates were prepared from 
wildtype, DCNL1 KO, and DCNL5 KO and processed for SDS-PAGE and 
immunoblotting for Cullin family members to assess the changes in the fraction of 
neddylated Cullins upon loss of DCNL1 or DCNL5.  DCNL1 knock-out has the 
strongest effect on Cul4A neddylation and had mild reduction of Cul3 and Cul5 
neddylation.  DCNL5 has reduced neddylation of all Cullins tested with the greatest 
effect on Cul4A, Cul4B, and Cul2.  Adjacent graphs show the means (± s.e.m.) of 
quantified percentage of neddylated Cullins.  Statistical significance was determined 
by one-way ANOVA with Newman-Keuls Multiple Comparison Test. *P≤0.05  
**P≤0.01  *** P≤0.001    n≥3.  
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Figure 5 
 DCNL1 and DCNL5 independently contribute to Cul4A neddylation 
A. Cul4A neddylation partly depends on DCNL1 expression. Western-blot analysis of 
lysates from U2OS cell lines stably expressing siRNA resistant transgenes for FLAG-
empty, FLAG-DCNL1(WT), or FLAG-DCNL1(DAD) mutant.  Cells were treated 
with control siRNA or siRNA to DCNL1 for 72 hours. Transgene expression was 
induced by doxycycline (0.5ng/ml) for 24 hours. Where indicated MLN4924 was 
added for 3 hours at 3mM. Cell lysates were resolved by SDS-PAGE and 
immunoblotted with Cul4A antibody to assess the fraction of neddylated Cullin. 
siRNA depeletion of DCNL1 reduces Cul4A neddylation, which can be rescued by re-
expression of DCNL1(WT) but not Cullin-binding deficient DAD mutant.  
B. Cul4A neddylation partly depends on DCNL5. Whole cell lysates were prepared as in 
(A) but cell lines stably expressed FLAG-empty, FLAG-DCNL5(WT) or FLAG-
DCNL5(DAD) and siRNA was targeted against DCNL5 or control.  siRNA mediated 
depletion of DCNL5 reduces the fraction of Cul4A that is neddylated.  Upon re-
expression of WT DCNL5 Cul4A neddylation is rescued to wildtype levels. The 
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Cullin binding deficient DAD patch mutant of DCNL5 fails to rescue Cul4A 
neddylation suggesting DCNL5 directly interacts with Cul4A to promote neddylation. 
C. Cul4A neddylation in DCNL1 KO cells directly depends on DCNL1 expression. 
Cul4A neddylation was assessed by western blot analysis of lysates from U2OS 
DCNL1 KO cell lines that stably express Flp-In generated GFP, GFP-DCNL1 WT, or 
GFP-DCNL1 DAD. Similar to the Cul4A neddylation reduction by siRNA depletion 
of DCNL1, knock-out of DCNL1 can only be rescued by re-expression of WT 
DCNL1, but not DAD patch mutant DCNL1.   
D. Cul4A neddylation in DCNL5 KO cells directly depends on DCNL5 expression. Same 
as in (C) except the U2OS knock-out cell line was DCNL5 and rescue lines were Flp-
In for GFP, GFP-DCNL5 WT, or GFP-DCNL5 DAD.  Cul4A neddylation is rescued 
by re-expression of WT but not DAD patch mutant DCNL5.   
E. DCNL5 depletion has an additive effect on Cul4A neddylation in DCNL1 KO cells. 
The fraction of neddylated Cul4A was determined by western blot analysis of cell 
lysates from WT or DCNL1 KO treated with control siRNA or siRNA against 
DCNL5. Additional depletion of DCNL5 in DCNL1 KO cells further reduces the 
amount of neddylated Cul4A.  This additive effect of DCNL5 depletion suggests there 
are separate pools of Cul4A that are independently neddylated by DCNL1 or DCNL5. 
F. DCNL1 depletion has an additive effect on Cul4A neddylation in DCNL5 KO cells. 
Same as in (E), but the cell lines were WT or DCNL5 KO and treatment was with 
control siRNA or siRNA against DCNL1.  The addition depletion of DCNL1 in 
DCNL5 KO cells mirrors the result in E and further supports that model that separate 
pools of Cul4A are independently regulated by DCNL1 or DCNL5 
All graphs in this panel plot the means ± s.e.m. of quantified percentage of neddylated 
Cul4A.  Statistical significance was determined by one-way ANOVA with Newman-
Keuls Multiple Comparison Test.  **P≤0.01  *** P≤0.001    n≥3. 
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Figure 6 
DCNL5 but not DCNL1 is involved in the DNA damage response 
A. Clonogenic survival analysis of U2OS cells (WT, DCNL1 KO, DCNL5 KO, and 
DCNL5 KO re-expressing WT DCNL5) carried out after UV exposure. 500 cells/well 
were plated in six-well plates and 24 hours later exposed to indicated amounts of UV 
radiation.  Cells were allowed to grow for 14 days and colony formation was assessed 
by crystal-violet staining. Cells able to form colonies are interpreted as having 
repaired the UV-induced damage. DCNL5 KO cells have an impaired ability to form 
colonies after UV exposure, suggesting defects in DNA repair mechanisms. DCNL1 
KO cells are not sensitive to DNA damage. Each datapoint is the average of three 
experiments undertaken in at least three replicates +/- SE. 
B. DCNL5 is recruited to sites of DNA damage.  Immunofluorescence of U2OS cells 
treated with BrdU (10 M, 24 h) (left panel) or mono-psoralen (25 M, 3h) (right 
panel). Cells were fixed 5-10 minutes after laser micro-irradiation and stained for 
endogenous DCNL5 or Cul4A, phosphorylated -H2AX and DAPI (scale bar = 
10m). The histone variant -H2AX, a marker ofor DNA damage, serves as a positive 
control.  DCNL5 and Cul4A are also recruited to the site of DNA damage.  
C. DCNL5 is recruited to DNA damage sites independently of Cullin binding. Live-cell 
analysis of U2OS cells stably expressing GFP, GFP-DCNL5(WT) or GFP-
DCNL5(DAD) mutant. Cells were BrdU treated (10M, 24h) and images captured at 
indicated times after micro-irradiation with a 355nm UV laser.  Both WT DCNL5 and 
mutant DCNL5 are recruited to DNA damage sites.   
D. DCNL recruitment to sites of DNA damage. U2OS cells were transfected with N-
terminally GFP-tagged DCNLs. 24 hours after transfection, cells were treated as in C. 
All slides were treated equal and images were taken with the same microscope with 
identical settings. All DCNLs are readily recruited to sites of DNA damage with the 
exception of DCNL3 that displays only very weak recruitment. 
E. U2OS cells transiently transfected with FLAG-DCNL3 or chimeric FLAG-DCNL3 
where the N-terminal domain (aa1-85) was replaced with the N-terminus domain of 
DCNL5 (aa1-46). Cells were treated as in C and D. Replacement of the N-terminus 
readily targets DCNL3 to sites of DNA damage.  
 
